12/24
07:01 pm
abbv
Top Stock Reports for AbbVie, Coca-Cola & Chevron [Yahoo! Finance]
Neutral
Report
Top Stock Reports for AbbVie, Coca-Cola & Chevron [Yahoo! Finance]
12/23
10:38 pm
abbv
2 Dividend Kings Quietly Beating the Market This Year [Yahoo! Finance]
Low
Report
2 Dividend Kings Quietly Beating the Market This Year [Yahoo! Finance]
12/22
06:30 pm
abbv
What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders [Yahoo! Finance]
Low
Report
What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders [Yahoo! Finance]
12/21
10:25 pm
abbv
????????????????????????????2035????128???????????? [CNET News]
Low
Report
????????????????????????????2035????128???????????? [CNET News]
12/19
04:10 pm
abbv
Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc [Yahoo! Finance]
Low
Report
Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc [Yahoo! Finance]
12/18
04:54 pm
abbv
Is AbbVie a Millionaire Maker? [Yahoo! Finance]
Low
Report
Is AbbVie a Millionaire Maker? [Yahoo! Finance]
12/16
08:03 am
abbv
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? [Yahoo! Finance]
Low
Report
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? [Yahoo! Finance]
12/14
08:00 pm
abbv
AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 List
Low
Report
AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 List
12/13
08:42 pm
abbv
Women's Healthcare Market Worth USD 46.76 Billion by 2033 Driven by Rising Demand for Reproductive, Preventive, and Digital Health Solutions – SNS Insider [Yahoo! Finance]
Low
Report
Women's Healthcare Market Worth USD 46.76 Billion by 2033 Driven by Rising Demand for Reproductive, Preventive, and Digital Health Solutions – SNS Insider [Yahoo! Finance]
12/12
12:55 pm
abbv
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 [Yahoo! Finance]
Low
Report
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 [Yahoo! Finance]
12/12
10:02 am
abbv
AbbVie (NYSE:ABBV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
AbbVie (NYSE:ABBV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/11
03:34 pm
abbv
Hot Picks: Large-cap health care stocks to watch for dividend growth [BNN Bloomberg (Canada)]
Low
Report
Hot Picks: Large-cap health care stocks to watch for dividend growth [BNN Bloomberg (Canada)]
12/11
11:48 am
abbv
Is AbbVie Stock Too Cheap to Ignore at Today's Price? [Yahoo! Finance]
Low
Report
Is AbbVie Stock Too Cheap to Ignore at Today's Price? [Yahoo! Finance]
12/11
06:28 am
abbv
AbbVie (NYSE:ABBV) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
Low
Report
AbbVie (NYSE:ABBV) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
12/10
07:01 am
abbv
AbbVie (NYSE:ABBV) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.
Low
Report
AbbVie (NYSE:ABBV) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.
12/5
03:27 am
abbv
AbbVie-Sponsored Symposium at ESMO Asia 2025 Highlights Urgent Medical Need in Platinum-Resistant Advanced Ovarian Cancer [Yahoo! Finance]
Low
Report
AbbVie-Sponsored Symposium at ESMO Asia 2025 Highlights Urgent Medical Need in Platinum-Resistant Advanced Ovarian Cancer [Yahoo! Finance]
12/3
04:54 pm
abbv
AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript [Seeking Alpha]
Low
Report
AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript [Seeking Alpha]
12/2
09:36 am
abbv
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers [Yahoo! Finance]
Low
Report
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers [Yahoo! Finance]
12/2
08:15 am
abbv
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers
Low
Report
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers
12/1
06:01 am
abbv
AbbVie: Increased Outlook For 2025 And Expansions Merit Continued "Strong Buy" Rating [Seeking Alpha]
Low
Report
AbbVie: Increased Outlook For 2025 And Expansions Merit Continued "Strong Buy" Rating [Seeking Alpha]
12/1
04:00 am
abbv
AbbVie to Present Phase 3 ECLIPSE Data Demonstrating Atogepant (AQUIPTA®) Superiority Over Placebo in Achieving Pain Freedom for the Acute Treatment of Migraine at the 19th European Headache Congress
Low
Report
AbbVie to Present Phase 3 ECLIPSE Data Demonstrating Atogepant (AQUIPTA®) Superiority Over Placebo in Achieving Pain Freedom for the Acute Treatment of Migraine at the 19th European Headache Congress
11/30
09:29 am
abbv
AbbVie (NYSE:ABBV) Will Pay A Larger Dividend Than Last Year At $1.73 [Yahoo! Finance]
Low
Report
AbbVie (NYSE:ABBV) Will Pay A Larger Dividend Than Last Year At $1.73 [Yahoo! Finance]
11/30
03:33 am
abbv
Low
Report
11/28
07:01 am
abbv
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance
Low
Report
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance
11/25
09:30 am
abbv
AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec
Low
Report
AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec